Enhancement of posterolateral lumbar spine fusion using low-dose rhBMP-2 and cultured marrow stromal cells

Journal of Orthopaedic Research

Volumn 27, Issue 3, 2009, Pages 380-384

  Fu, Tsai Sheng ^a   Chen, Wen Jer ^a   Chen, Lih Huei ^a   Lin, Song Shu ^a   Liu, Shih Jung ^a   Ueng, Steve W N ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Bone regeneration; Posterolateral fusion; rhBMP 2; Stem cell

Indexed keywords

ALGINIC ACID; BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT PROTEIN; BMP2 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; BONE DEVELOPMENT; BONE GRAFT; BONE MARROW CULTURE; BONE REGENERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; EXPERIMENTAL RABBIT; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; ILIAC BONE; IN VITRO STUDY; LUMBAR SPINE; MALE; MECHANICAL STRESS; NONHUMAN; PRIORITY JOURNAL; SPINE FUSION; STROMA CELL; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; HUMAN; LUMBAR VERTEBRA; MECHANICAL TORSION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; RABBIT; RADIOGRAPHY;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CELLS, CULTURED; HUMANS; LUMBAR VERTEBRAE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; OSTEOGENESIS; RABBITS; RECOMBINANT PROTEINS; SPINAL FUSION; TORSION, MECHANICAL;

EID: 62249105227     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20644     Document Type: Article

References (23)

1. Boden SD, Martin GJ Jr, Morone MA, et al. 1999. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite- tricalcium phosphate after laminectomy in the nonhuman primate. Spine 24:1179-1185.
2. Cook SD, Dalton JE, Tan EH, et al. 1994. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine 19:1655-1663.
3. Sandhu HS, Kanim LE, Kabo JM, et al. 1996. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 21:2115-2122.
4. Schimandle JH, Boden SD, Hutton WC. 1995. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 20:1326-1337.
5. Pittenger MF, Mackay AM, Beck SC, et al. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
6. Caplan AI. 2005. Mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Engineering 11:1998-1211.
7. Solchaga LA, Johnstone B, Yoo JU, et al. 1999. High variability in rabbit bone marrow-derived mesenchymal cell preparations. Cell Transplant 8:511-519.
8. Noshi T, Yoshikawa T, Dohi Y, et al. 2001. Recombinant human bone morphogenetic potein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites. Artif Organs 25:201-208.
9. Tsiridis E, Bhalla A, Ali Z, et al. 2006. Enhancing the osteoinductive properties of hydroxyapatite by the addition of human mesenchymal stem cells, and recombinant human osteogenic protein-1 (BMP-7) in vitro. Injury 37(Suppl 3):S25-S32.
10. Ueng SW, Lee MS, Lin SS, et al. 2007. Development of a biodegradable alginate carrier system for antibiotics and bone cells. J Orthop Res 25:62-72.
11. Itoh H, Ebara S, Kamimura M, et al. 1999. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2. Spine 24:1402-1405.
12. Konishi S, Nakamura H, Seki M, et al. 2002. Hydroxyapatite granule graft combined with recombinant human bone morphogenic protein-2 for solid lumbar fusion. J Spinal Disord Tech 15:237-244.
13. Minamide A, Kawakami M, Hashizume H, et al. 2001. Evaluation of carriers of bone morphogenetic protein for spinal fusion. Spine 26:933-939.
14. Namikawa T, Terai H, Suzuki E, et al. 2005. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and β-tricalcium phosphate in a rabbit model. Spine 30:1717-1722.
15. Lindholm TS, Urist MR. 1980. A quantitative analysis of new bone formation by induction in composite grafts of bone marrow and bone matrix. Clin Orthop 150:288-300.
16. Werntz JR, Lane JM, Brustein AH, et al. 1996. Qualitative and quantitative analysis of orthotopic bone regeneration by marrow. J Orthop Res 14:85-93.
17. Minamide A, Yoshida M, Kawakami M, et al. 2005. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion. Spine 30:1134-1138.
18. Kwon B, Jenis LG. 2005. Carrier materials for spinal fusion. Spine J 5:224S-230S.
19. Aydelotte MB, Thonar EJM, Mollenhauer J, et al. 1998. Culture of chondrocytes in alginate gel: variations in conditions of gelation influence the structure of the alginate gel, and the arrangement and morphology of proliferating chondrocytes. In Vitro Cell Dev Biol Anim 34:123-130.
20. Downs EC, Robertson NE, Riss TL, et al. 1992. Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro. J Cell Physiol 152:422-429.
21. Joly A, Deshardins JF, Fremond B, et al. 1997. Survival proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a reliable bioartificial liver. Transplant 63:795-803.
22. Ueng SW, Lee SS, Lin SS, et al. 2000. Biodegradable alginate antibiotic beads. Clin Orthop 380:250-259.
23. Toribatake Y, Hutton WC, Tomita K, Boden SD. 1998. Vascularization of the fusion mass in a posterolateral intertransverse process fusion. Spine 23:1149-1154.